Literature DB >> 6367899

Allogeneic marrow transplantation.

K M Sullivan, R Storb.   

Abstract

After 15 years of clinical investigation, allogeneic marrow transplantation can be considered the treatment of choice for a variety of hematologic and immunologic diseases. This review has focused upon some of the principles, current results, problems, and future directions in allogeneic marrow grafting.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6367899     DOI： 10.3109/07357908409020284

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


  5 in total

1.  Laminar air flow isolation and decontamination: a prospective randomized study of the effects of prophylactic systemic antibiotics in bone marrow transplant patients.

Authors:  F B Petersen; C D Buckner; R A Clift; S Lee; N Nelson; G W Counts; J D Meyers; J E Sanders; P S Stewart; W I Bensinger
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

2.  The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study.

Authors:  F Petersen; M Thornquist; C Buckner; G Counts; N Nelson; J Meyers; R Clift; E Thomas
Journal:  Infection       Date:  1988 Jul-Aug       Impact factor: 3.553

3.  Prognostic indicators of mortality of mechanically ventilated patients with acute leukemia in a comprehensive cancer center.

Authors:  K J Price; M Cardenas-Turanzas; H Lin; L Roden; R Nigam; J L Nates
Journal:  Minerva Anestesiol       Date:  2012-10-02       Impact factor: 3.051

4.  Outcome and prognostic indicators of patients with hematopoietic stem cell transplants admitted to the intensive care unit.

Authors:  Thanh N Huynh; S Sam Weigt; John A Belperio; Mary Territo; Michael P Keane
Journal:  J Transplant       Date:  2009-09-15

5.  Outcome of allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies.

Authors:  Mohammad Faizan Zahid; Natasha Ali; Mohammad Usman Shaikh; Salman Naseem Adil
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.